3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
30
Myelodysplastic Syndromes
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Leukemia
17
Multiple Myeloma
13
Lymphoma, Non-Hodgkin
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Lymphoma
11
Hodgkin Disease
11
Myeloproliferative Disorders
9
Congenital Abnormalities
9
Neoplasms, Plasma Cell
8
Leukemia, Myeloid, Accelerated Phase
8
Blast Crisis
8
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia, Myeloid, Chronic-Phase
7
Primary Myelofibrosis
6
Myelodysplastic-Myeloproliferative Diseases
6
Lymphoma, Mantle-Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Myelomonocytic, Juvenile
6
Lymphoma, Large-Cell, Immunoblastic
5
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
5
Hematologic Neoplasms
5
Graft vs Host Disease
5
Burkitt Lymphoma
5
Sezary Syndrome
4
Interventions
fludarabine phosphate
2
Cyclophosphamide
2
AP 1903 reagent
2
fludarabine
1
Whole-Body Irradiation
1
Peripheral Blood Stem Cell Transplantation
1
Mesna
1
Busulfan
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Thalassemia
×
Busulfan
×
Clear all
NCT00578292
2020-05-01
THALLO
Baylor College of Medicine
Phase NA
Terminated
10 enrolled
15 charts